Request Deal Involvement

Science 37 went public via a SPAC merger with LifeSci Acquisition II in a $1bn deal.

Identify your role

Select the side you represented in this transaction, and provide your current job title.

Service Providers

Perella Weinberg Partners

financial advisors

Perella Weinberg Partners

DLA Piper

legal advisors

DLA Piper

TD Cowen

financial advisors

TD Cowen

Latham & Watkins

legal advisors

Latham & Watkins

Gilmartin Group

pr advisors

Gilmartin Group

10Fold Communications

pr advisors

10Fold Communications

Shearman & Sterling

legal advisors to financial advisors

Shearman & Sterling

Loeb & Loeb

legal advisors

Loeb & Loeb

TD Cowen

financial advisors

TD Cowen

LifeSci Partners

financial advisors

LifeSci Partners

Simpson Thacher & Bartlett

legal advisors

Simpson Thacher & Bartlett

or

Principals

SCIENCE 37 INC

target

SCIENCE 37 INC

LIFESCI VENTURE PARTNERS

bidder

LIFESCI VENTURE PARTNERS

LIFESCI ACQUISITION II CORP

bidder

LIFESCI ACQUISITION II CORP

REDMILE GROUP

bidder

REDMILE GROUP

RS INVESTMENTS

bidder

RS INVESTMENTS

PHARMACEUTICAL PRODUCT DEVELOPMENT LLC

bidder

PHARMACEUTICAL PRODUCT DEVELOPMENT LLC

BLACKROCK

bidder

BLACKROCK

CASDIN CAPITAL

bidder

CASDIN CAPITAL

LUX CAPITAL MANAGEMENT

bidder

LUX CAPITAL MANAGEMENT

RTW INVESTMENTS

bidder

RTW INVESTMENTS

SAMSARA BIOCAPITAL

bidder

SAMSARA BIOCAPITAL

DRX CAPITAL

bidder

DRX CAPITAL

MUBADALA CAPITAL

bidder

MUBADALA CAPITAL

PERCEPTIVE ADVISORS LLC

bidder

PERCEPTIVE ADVISORS LLC

PURA VIDA INVESTMENTS

bidder

PURA VIDA INVESTMENTS

SURVEYOR CAPITAL

bidder

SURVEYOR CAPITAL

Principals or Service Provider not listed?Add missing Service Provider or Principal

Enter your Job Title on this deal

This title will appear on your profile next to this deal involvement.


To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:

All rights reserved. Copyright © 2025 Datasite

MergerLinks - Request Credit - Science 37 went public via a SPAC merger with LifeSci Acquisition II in a $1bn deal.